GNE-7915 10 mg | Purity Not Available
TargetMol
GNE-7915 is a highly potent, selective and brain-penetrable leucine-rich repeat kinase 2 (LRRK2) inhibitor.
More Information Supplier PageGNE-7915
Search Results
GNE-7915 100 mg | Purity Not Available
TargetMol
GNE-7915 is a highly potent, selective and brain-penetrable leucine-rich repeat kinase 2 (LRRK2) inhibitor.
More Information Supplier PageGNE-7915
MDL-29951 5 mg | 99.07%
TargetMol
MDL-29951
MDL-29951 50 mg | 99.07%
TargetMol
MDL-29951
VGX-1027 5 mg | Purity Not Available
TargetMol
VGX-1027 (GIT 27) is an isoxazole compound with various immunomodulatory properties.
More Information Supplier PageVGX-1027
VGX-1027 50 mg | Purity Not Available
TargetMol
VGX-1027 (GIT 27) is an isoxazole compound with various immunomodulatory properties.
More Information Supplier PageVGX-1027
VGX-1027 25 mg | Purity Not Available
TargetMol
VGX-1027 (GIT 27) is an isoxazole compound with various immunomodulatory properties.
More Information Supplier PageVGX-1027
VGX-1027 10 mg | Purity Not Available
TargetMol
VGX-1027 (GIT 27) is an isoxazole compound with various immunomodulatory properties.
More Information Supplier PageVGX-1027
Purmorphamine 5 mg | 98.11%
TargetMol
Purmorphamine, which directly binds and activates Smoothened, blocks BODIPY-cyclopamine binding to Smo. It also is an inducer of osteoblast differentiation.
More Information Supplier PagePurmorphamine
Purmorphamine 50 mg | 98.11%
TargetMol
Purmorphamine, which directly binds and activates Smoothened, blocks BODIPY-cyclopamine binding to Smo. It also is an inducer of osteoblast differentiation.
More Information Supplier PagePurmorphamine